Safety and activity of nivolumab monotherapy in advanced and metastatic (A/M) gastric or gastroesophageal junction cancer (GC/GEC): Results from the CheckMate-032 study Meeting Abstract


Authors: Le, D. T.; Bendell, J. C.; Calvo, E.; Kim, J. W.; Ascierto, P. A.; Sharma, P.; Ott, P. A.; Bono, P.; Jaeger, D.; Evans, T. R. J.; De Braud, F. G.; Chau, I.; Christensen, O.; Harbison, C.; Lin, C. S.; Janjigian, Y. Y.
Abstract Title: Safety and activity of nivolumab monotherapy in advanced and metastatic (A/M) gastric or gastroesophageal junction cancer (GC/GEC): Results from the CheckMate-032 study
Meeting Title: 2016 Gastrointestinal Cancers Symposium
Journal Title: Journal of Clinical Oncology
Volume: 34
Issue: 4 Suppl.
Meeting Dates: 2016 Jan 21-23
Meeting Location: San Francisco, CA
ISSN: 0732-183X
Publisher: American Society of Clinical Oncology  
Date Published: 2016-02-01
Language: English
ACCESSION: WOS:000378109600007
PROVIDER: wos
DOI: 10.1200/jco.2016.34.4_suppl.6
Notes: Meeting Abstract: 6 -- Gastrointestinal Cancers Symposium -- JAN 21-23, 2016 -- San Francisco, CA -- S -- Source: Wos
Altmetric
Citation Impact
BMJ Impact Analytics
MSK Authors
  1. Yelena Yuriy Janjigian
    394 Janjigian